Annual ROE
-32.08%
+0.19%+0.59%
31 December 2023
Summary:
Lineage Cell Therapeutics annual return on equity is currently -32.08%, with the most recent change of +0.19% (+0.59%) on 31 December 2023. During the last 3 years, it has fallen by -12.07% (-60.32%). LCTX annual ROE is now -113.21% below its all-time high of 242.93%, reached on 31 December 2002.LCTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-30.35%
+5.45%+15.22%
30 September 2024
Summary:
Lineage Cell Therapeutics quarterly return on equity is currently -30.35%, with the most recent change of +5.45% (+15.22%) on 30 September 2024. Over the past year, it has increased by +2.01% (+6.21%). LCTX quarterly ROE is now -103.99% below its all-time high of 760.58%, reached on 30 June 2004.LCTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.6% | +6.2% |
| 3 y3 years | -60.3% | -175.9% |
| 5 y5 years | +10.5% | +22.0% |
LCTX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -60.3% | +30.6% | -175.9% | +43.6% |
| 5 y | 5 years | -178.7% | +30.6% | -217.1% | +43.6% |
| alltime | all time | -113.2% | +98.8% | -104.0% | +98.8% |
Lineage Cell Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -30.35%(-15.2%) |
| June 2024 | - | -35.80%(+2.9%) |
| Mar 2024 | - | -34.79%(+10.4%) |
| Dec 2023 | -32.08%(-0.6%) | -31.51%(-2.6%) |
| Sept 2023 | - | -32.36%(+9.1%) |
| June 2023 | - | -29.66%(-3.0%) |
| Mar 2023 | - | -30.58%(-5.2%) |
| Dec 2022 | -32.27%(-30.2%) | -32.27%(-40.0%) |
| Sept 2022 | - | -53.77%(+6.3%) |
| June 2022 | - | -50.58%(+11.3%) |
| Mar 2022 | - | -45.43%(+15.3%) |
| Dec 2021 | -46.25%(+131.1%) | -39.41%(+258.3%) |
| Sept 2021 | - | -11.00%(-3.5%) |
| June 2021 | - | -11.40%(-15.9%) |
| Mar 2021 | - | -13.55%(-34.5%) |
| Dec 2020 | -20.01%(+73.8%) | -20.69%(-20.9%) |
| Sept 2020 | - | -26.15%(-18.3%) |
| June 2020 | - | -32.00%(-32.7%) |
| Mar 2020 | - | -47.57%(+397.1%) |
| Dec 2019 | -11.51%(-67.9%) | -9.57%(-75.4%) |
| Sept 2019 | - | -38.92%(-265.3%) |
| June 2019 | - | 23.54%(-47.8%) |
| Mar 2019 | - | 45.12%(-224.3%) |
| Dec 2018 | -35.86%(+164.6%) | -36.31%(-25.4%) |
| Sept 2018 | - | -48.65%(-41.1%) |
| June 2018 | - | -82.63%(+5.0%) |
| Mar 2018 | - | -78.72%(+586.9%) |
| Dec 2017 | -13.55%(-141.8%) | -11.46%(-141.2%) |
| Sept 2017 | - | 27.79%(-36.5%) |
| June 2017 | - | 43.75%(-46.6%) |
| Mar 2017 | - | 81.92%(+142.6%) |
| Dec 2016 | 32.44%(-148.0%) | 33.77%(+14.5%) |
| Sept 2016 | - | 29.50%(-207.1%) |
| June 2016 | - | -27.55%(-67.3%) |
| Mar 2016 | - | -84.29%(+15.9%) |
| Dec 2015 | -67.53%(-2.7%) | -72.71%(-5.9%) |
| Sept 2015 | - | -77.29%(+8.1%) |
| June 2015 | - | -71.49%(-6.8%) |
| Mar 2015 | - | -76.73%(-0.8%) |
| Dec 2014 | -69.37%(-47.4%) | -77.31%(-32.5%) |
| Sept 2014 | - | -114.59%(-3.8%) |
| June 2014 | - | -119.10%(-4.5%) |
| Mar 2014 | - | -124.69%(-11.1%) |
| Dec 2013 | -131.87%(+102.3%) | -140.27%(+32.7%) |
| Sept 2013 | - | -105.69%(+22.6%) |
| June 2013 | - | -86.22%(+9.6%) |
| Mar 2013 | - | -78.67%(+21.3%) |
| Dec 2012 | -65.17%(+79.3%) | -64.88%(+17.4%) |
| Sept 2012 | - | -55.27%(+17.4%) |
| June 2012 | - | -47.09%(+15.9%) |
| Mar 2012 | - | -40.62%(+16.2%) |
| Dec 2011 | -36.34%(-1.8%) | -34.95%(+15.4%) |
| Sept 2011 | - | -30.28%(-12.2%) |
| June 2011 | - | -34.47%(-4.8%) |
| Mar 2011 | - | -36.20%(-8.5%) |
| Dec 2010 | -36.99%(-75.9%) | -39.55%(+11.9%) |
| Sept 2010 | - | -35.35%(-30.0%) |
| June 2010 | - | -50.52%(-59.2%) |
| Mar 2010 | - | -123.81%(-75.6%) |
| Dec 2009 | -153.56%(-276.5%) | -506.43%(-192.9%) |
| Sept 2009 | - | 544.88%(+261.3%) |
| June 2009 | - | 150.83%(+40.9%) |
| Mar 2009 | - | 107.02%(+16.3%) |
| Dec 2008 | 86.98% | 92.01%(+36.9%) |
| Sept 2008 | - | 67.19%(+31.7%) |
| June 2008 | - | 51.03%(+11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | 45.82%(-13.2%) |
| Dec 2007 | 47.21%(-52.8%) | 52.78%(-13.9%) |
| Sept 2007 | - | 61.33%(-20.0%) |
| June 2007 | - | 76.70%(-30.6%) |
| Mar 2007 | - | 110.57%(-21.9%) |
| Dec 2006 | 99.97%(-103.6%) | 141.49%(-35.5%) |
| Sept 2006 | - | 219.38%(-15.5%) |
| June 2006 | - | 259.64%(-4.9%) |
| Mar 2006 | - | 273.00%(-21.9%) |
| Dec 2005 | -2799.47%(+212.9%) | 349.75%(-24.9%) |
| Sept 2005 | - | 465.89%(-164.3%) |
| June 2005 | - | -725.06%(+163.3%) |
| Mar 2005 | - | -275.34%(-67.3%) |
| Dec 2004 | -894.81%(-1348.5%) | -843.14%(-0.2%) |
| Sept 2004 | - | -844.67%(-211.1%) |
| June 2004 | - | 760.58%(+242.9%) |
| Mar 2004 | - | 221.80%(+161.6%) |
| Dec 2003 | 71.67%(-70.5%) | 84.78%(-23.2%) |
| Sept 2003 | - | 110.37%(-47.0%) |
| June 2003 | - | 208.40%(-12.6%) |
| Mar 2003 | - | 238.37%(-19.8%) |
| Dec 2002 | 242.93%(-140.5%) | 297.23%(-23.9%) |
| Sept 2002 | - | 390.39%(+12.3%) |
| June 2002 | - | 347.76%(-45.9%) |
| Mar 2002 | - | 643.19%(-126.2%) |
| Dec 2001 | -600.48%(+290.2%) | -2450.31%(+269.3%) |
| Sept 2001 | - | -663.57%(+101.6%) |
| June 2001 | - | -329.21%(+54.6%) |
| Mar 2001 | - | -213.01%(+30.0%) |
| Dec 2000 | -153.89%(+5.1%) | -163.89%(+23.7%) |
| Sept 2000 | - | -132.49%(+7.6%) |
| June 2000 | - | -123.14%(+31.3%) |
| Mar 2000 | - | -93.82%(+7.2%) |
| Dec 1999 | -146.46%(+123.2%) | -87.51%(+3.7%) |
| Sept 1999 | - | -84.42%(+44.5%) |
| June 1999 | - | -58.42%(-10.9%) |
| Mar 1999 | - | -65.54%(-5.1%) |
| Dec 1998 | -65.63%(-1.6%) | - |
| Sept 1998 | - | -69.04%(+16.9%) |
| June 1998 | - | -59.04%(-2.0%) |
| June 1998 | -66.67%(+3.3%) | - |
| Mar 1998 | - | -60.26%(+8.5%) |
| Dec 1997 | - | -55.56%(-17.2%) |
| Sept 1997 | - | -67.07%(-4.8%) |
| June 1997 | -64.52%(-3.2%) | -70.42%(-0.3%) |
| Mar 1997 | - | -70.62%(-27.7%) |
| Dec 1996 | - | -97.74%(+24.6%) |
| Sept 1996 | - | -78.43%(+37.3%) |
| June 1996 | -66.67%(+25.0%) | -57.14%(-20.8%) |
| Mar 1996 | - | -72.13%(+10.4%) |
| Dec 1995 | - | -65.35%(+19.4%) |
| Sept 1995 | - | -54.73%(+4.9%) |
| June 1995 | -53.33%(+63.5%) | -52.17%(+29.7%) |
| Mar 1995 | - | -40.23%(+10.9%) |
| Dec 1994 | - | -36.29%(+7.1%) |
| Sept 1994 | - | -33.90%(+4.6%) |
| June 1994 | -32.61%(+8.7%) | -32.41%(-2.3%) |
| Mar 1994 | - | -33.16%(-4.4%) |
| Dec 1993 | - | -34.68%(+19.8%) |
| Sept 1993 | - | -28.95%(+6.3%) |
| June 1993 | -30.00%(+97.1%) | -27.23%(+18.2%) |
| Mar 1993 | - | -23.04%(+3.1%) |
| Dec 1992 | - | -22.35%(+47.9%) |
| Sept 1992 | - | -15.11%(+79.5%) |
| June 1992 | -15.22% | -8.42%(+106.4%) |
| Mar 1992 | - | -4.08% |
FAQ
- What is Lineage Cell Therapeutics annual return on equity?
- What is the all time high annual ROE for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics annual ROE year-on-year change?
- What is Lineage Cell Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics quarterly ROE year-on-year change?
What is Lineage Cell Therapeutics annual return on equity?
The current annual ROE of LCTX is -32.08%
What is the all time high annual ROE for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high annual return on equity is 242.93%
What is Lineage Cell Therapeutics annual ROE year-on-year change?
Over the past year, LCTX annual return on equity has changed by +0.19% (+0.59%)
What is Lineage Cell Therapeutics quarterly return on equity?
The current quarterly ROE of LCTX is -30.35%
What is the all time high quarterly ROE for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high quarterly return on equity is 760.58%
What is Lineage Cell Therapeutics quarterly ROE year-on-year change?
Over the past year, LCTX quarterly return on equity has changed by +2.01% (+6.21%)